Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. - Wikidata - awgldk - TriplyDB

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.

http://www.wikidata.org/entity/Q36892959

about

Radiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-Analysis Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.Role of Nutrition and Muscle in Cirrhosis.A practical approach to nutritional screening and assessment in cirrhosis.A multicenter study to define sarcopenia in patients with end-stage liver disease.Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.Physical activity for the prevention and treatment of sarcopenic obesity.Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality.The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study.Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017.Liver Transplantation in the Obese Cirrhotic Patient.Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.Nutrition and Muscle in Cirrhosis.Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C.An analysis of the types of recently published research in the field of cachexia.Nutrition and the transplant candidate.Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.Muscle fat infiltration assessed by total psoas density on computed tomography predicts mortality in cirrhosis.Physical Activity in Liver Transplantation: A Patient's and Physicians' Experience Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018 Intramuscular Adipose Tissue and the Functional Components of Sarcopenia in Hospitalized Geriatric Patients.Nutritional issues in patients with obesity and cirrhosis

P2860

Q29994656-E9BDA37B-4E35-4DBF-BB9E-240CA92FFD73 Q33879877-56D8A20D-1445-416D-A0CE-199AFC5CBF5B Q38792500-718B22A1-D7BD-405D-828E-C439FA1017EC Q39058937-FF3A9EA7-4040-45DD-BE3C-AF8D07DD370C Q40316947-E2321490-C145-4A45-B1CD-338BC60C1566 Q41328355-012FDE46-DF2C-44BB-8DD9-AD8098D99C88 Q42336591-B85817A2-64FE-46F4-9CCA-E14604F56B9E Q42337444-934F1D1B-A466-454E-8F02-7597975EE730 Q44877545-4822BD5E-FB91-4D96-8C55-F782D076F13C Q46213438-6BC5831D-E018-42F0-BE40-C6D33CAE5254 Q46569927-BA9BA4A7-56F4-4B7A-A788-F4BABA6E1FF3 Q47132964-66E7BAA2-FA53-4B29-AB58-0216F8A383ED Q47290527-250CCE04-2C34-46CE-BAEC-DB9FEF7910C8 Q47300465-58B70932-8CDE-4179-A6E2-83D711740E55 Q47551529-B3BBA2A0-525C-4CBB-A6F4-467488612EFE Q47568983-5381B883-1059-4007-8BD2-51900922971E Q47600945-47BC426F-84F0-4600-B85A-EC42B0AE738E Q47990669-43E71E3E-0B23-48C8-9453-167A42AA98D5 Q48198814-D36D48BF-A7F5-44EF-9BB2-842F7EF993AF Q55263120-BF0BDD73-D8A9-4269-9EAA-6C80EB503AB6 Q55505729-05E08E3E-E39D-4C75-99B3-B8F8DF4D96DC Q57455317-16E3DF18-E797-44EB-A755-7C00690EFC9E Q57476138-F0726D0A-6D86-47A5-B160-BEE77E13349D Q58045479-EBE92EFA-95BA-4174-91C5-E76586502823 Q58782777-2814CCA6-71E1-46E1-A2D4-7E2E5D004A70

P2860

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.

http://www.wikidata.org/entity/Q36892959

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sarcopenic obesity and myostea ...... ty in patients with cirrhosis.

@en

type

label

Sarcopenic obesity and myostea ...... ty in patients with cirrhosis.

@en

prefLabel

Sarcopenic obesity and myostea ...... ty in patients with cirrhosis.

@en

P1433

Q36892959-AF395B09-C2AD-4824-947C-9E86ADE492CB

P1476

Q36892959-A3F443F0-F318-431D-9073-167594B5171C

P2093

Q36892959-0FF0DBFD-7C2F-4628-B888-747816749BE4

Q36892959-723BBAF0-7A8A-4FB1-973D-C8C7C2CEC843

Q36892959-8E0E0B30-8B58-46B2-B06E-CA1C4F48F8E0

Q36892959-A6E26537-184B-4F94-A128-D2CE7BAF41D0

Q36892959-BB31FB89-BBD4-4C65-8298-1A26922D8387

Q36892959-D60FBC19-87E2-47FC-941E-E19F66ADA9CE

Q36892959-DBA2A3FD-A3C7-49FE-A68C-DA14CF85C724

Q36892959-DC1CF73C-0FC2-43C1-B4D7-F0C570F8D9E3

P2860

Q36892959-00575457-24F4-47BB-A449-195FAB77122E

Q36892959-03121CA3-A306-46B2-B2A2-5D6F09D7B438

Q36892959-0A43F929-393C-4741-A1BE-43C92C7C0A7A

Q36892959-12384A86-8A0C-42A2-A7B5-95D7320B3E2B

Q36892959-153E73F9-FF99-4B47-81D3-FA2686FACA30

Q36892959-18A22A0B-939F-4753-89B8-35B3CDD5D244

Q36892959-1BE9D0D4-D5A3-423F-ADC7-4A897A6A0F83

Q36892959-1D267DDB-244A-4BE6-954D-F60DA7382080

Q36892959-2DFEEAF4-3398-4920-9348-F5C4E783A430

Q36892959-325728E0-1F26-4FEF-88C2-05FF5B8179E0

P304

Q36892959-1B1429ED-5755-4D12-9BEF-41A2B365B73E

P31

Q36892959-B45B56C2-E0A7-406E-9721-8238E9A12700

P356

Q36892959-38918B53-C43A-4F08-B388-51543672C94C

P433

Q36892959-AAB2092D-2C17-4B1A-B88F-495C74C21C41

P478

Q36892959-2EC4A500-417F-48BE-8DA1-FF13D83D1FD9

P50

Q36892959-537EC698-9CCE-4196-819C-FF820AE2AF03

P577

Q36892959-56C84D7B-18C3-493F-B326-04A2AEC87C67

P5875

Q36892959-5A43B5A9-D9AC-4200-ABEE-9BDC3DF1E139

P698

Q36892959-6D81590A-F1A5-44A7-AEF9-C5019CD6FCC4

P932

Q36892959-2332C4E5-7BDE-424D-BC76-1D168032D568

P356

P1433

Journal of Cachexia, Sarcopenia and Muscle

P1476

Sarcopenic obesity and myostea ...... ty in patients with cirrhosis.

@en

P2093

Carla M M Prado

http://www.w3.org/2001/XMLSchema#string

Crystal Beaumont

http://www.w3.org/2001/XMLSchema#string

Judith Meza-Junco

http://www.w3.org/2001/XMLSchema#string

Mang Ma

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

Nina Esfandiari

http://www.w3.org/2001/XMLSchema#string

Paul Angulo

http://www.w3.org/2001/XMLSchema#string

Vickie E Baracos

http://www.w3.org/2001/XMLSchema#string

P2860

Global nutrition transition and the pandemic of obesity in developing countries

Epidemiology of sarcopenia among the elderly in New Mexico

Cancer cachexia: impact, mechanisms and emerging treatments

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells.

Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Sarcopenia and mortality after liver transplantation.

Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue.

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.

Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial

P304

126-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCSM.12039

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Aldo J Montano-Loza

P577

2015-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279221307

http://www.w3.org/2001/XMLSchema#string

P698

27493866

http://www.w3.org/2001/XMLSchema#string

P932

4864157

http://www.w3.org/2001/XMLSchema#string